Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Update Il y a 4 ans
Reference: NCT00410930

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare versus placebo the efficacy and safety of recombinant Bet v1, natural purified Bet v1 and birch pollen licenced extract used for subcutaneous immunotherapy.


Inclusion criteria

  • Allergy

Links